Cash · 2011–2025
Novavax cash
$241M−54.6% · FY2025
Novavax (NVAX) reported $241M in cash for fiscal 2025, −54.6% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $241M | −54.6% | Open → |
| FY20242024-12-31 | $530M | −6.7% | Open → |
| FY20232023-12-31 | $569M | −57.5% | Open → |
| FY20222022-12-31 | $1.3B | −11.8% | Open → |
| FY20212021-12-31 | $1.5B | +173.8% | Open → |
| FY20202020-12-31 | $553M | +602.1% | Open → |
| FY20192019-12-31 | $78.8M | +12.4% | Open → |
| FY20182018-12-31 | $70.2M | −34.0% | Open → |
| FY20172017-12-31 | $106M | −26.4% | Open → |
| FY20162016-12-31 | $144M | +55.0% | Open → |
| FY20152015-12-31 | $93.1M | +187.9% | Open → |
| FY20142014-12-31 | $32.3M | −72.9% | Open → |
| FY20132013-12-31 | $119M | +586.7% | Open → |
| FY20122012-12-31 | $17.4M | +23.4% | Open → |
| FY20112011-12-31 | $14.1M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +22.5%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Novavax cash |url=https://companiesranked.com/en/company/novavax/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Novavax cash. CompaniesRanked. https://companiesranked.com/en/company/novavax/cash-on-handBibTeX
@misc{companiesranked-en-company-novavax-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Novavax cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/novavax/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001000694-26-000018 · August 6, 2026
{{cite web |title=Novavax cash — 10-Q (0001000694-26-000018) |url=https://www.sec.gov/Archives/edgar/data/1000694/000100069426000018/nvax-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.